2019 House Bill 5045

Exempt epilepsy drugs from prescription reporting mandate

Introduced in the House

Oct. 8, 2019

Introduced by Rep. Hank Vaupel (R-47)

To exempt certain drugs used to treat epilepsy or seizure disorders from a law that requires doctors and pharmacists to report all schedule 2, 3, 4, and 5 controlled substances that they prescribe and dispense to the state through an electronic reporting system.

Referred to the Committee on Health Policy